Results 141 to 150 of about 2,248,898 (337)
FEBS Open Bio, EarlyView.The inactivation of SLC35C1 (GDP‐fucose transporter) and enzymes involved in GDP‐fucose biosynthesis was studied. Fucose supplementation increases the level of GDP‐fucose to abnormal, millimolar values in the absence of the TSTA3 protein and SLC35C1 in contrast to the GMDS/SLC35C1 double mutant.
Edyta Skurska, Mariusz Olczak
wiley +1 more source
Marketspace: Leading biotechnology players, 2002–08: Key products, indications and technologies
, 1969 Alex K Pavlou
openalex +2 more sources
The magic of the century we live in. The supremacy of three bio factors and their impact on firms trading [PDF]
Technology has come to be appreciated as key to the competitiveness of micro and macroeconomic level. Technological environment affecting business firms by increasing trade efficiency in making services and quality of services. Usually there should be no
ENEA Constanta +1 more
core
KWS: Going beyond sugar beet [PDF]
, 2001 Includes bibliographical references.KWS, a German seed company, is a world market leader in sugar beet seed. The company is looking for expansion into other crops—maize and cereals—and into other regions of the world—Eastern Europe and North America ...
Bijman, J.
core +1 more source
FEBS Open Bio, EarlyView.In the blood–testis barrier, occludin is crucial for tight junctions. This study demonstrates that occludin‐targeting short peptides disrupt junction integrity, inducing immune cell infiltration, tumor necrosis factor‐α/interleukin‐6 secretion and mitochondrial dysfunction, ultimately triggering apoptosis.
Heng Wang, Xiaofang Tan, Deyu Chen
wiley +1 more source
Cloning an industry: Strategy typologies of Shanghai biotechnology companies
, 1969 Ken Malone +4 more
openalex +2 more sources
THE ROLE OF GENE TRANSFER IN ANIMAL AGRICULTURE AND BIOTECHNOLOGY [PDF]
, 1985 Thomas E. Wagner
openalex +1 more source
The Birth of German Biotechnology Industry: Did Venture Capital run the Show? [PDF]
The goal of this paper is to point out the role played by private equity investors (venture-capital companies and corporate investors) in the emergence of a new biotechnology industry in Germany in the second half of the 90?s.
Champenois, Claire +2 more
core